A detailed history of Umb Bank, N.A. transactions in Innoviva, Inc. stock. As of the latest transaction made, Umb Bank, N.A. holds 110 shares of INVA stock, worth $2,079. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110
Previous 61 80.33%
Holding current value
$2,079
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$16.33 - $20.04 $800 - $981
49 Added 80.33%
110 $2,000
Q2 2024

Jul 29, 2024

BUY
$14.4 - $16.4 $504 - $574
35 Added 134.62%
61 $1,000
Q1 2024

Apr 26, 2024

BUY
$14.56 - $16.78 $378 - $436
26 New
26 $0

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.32B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Umb Bank, N.A. Portfolio

Follow Umb Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.